Infrared glucose sensor
First Claim
1. A blood-glucose detection apparatus comprising:
- infrared illumination means for non-invasively illuminating an in vivo blood sample in a patient at least two wavelengths in the near infrared spectrum;
detector means for non-invasively measuring light absorbed by said sample at least a first glucose data wavelength about 1600 nm and a second reference wavelength, and for converting said detected light into electrical signals, said signals being indicative of the intensity of said detected light at each wavelength;
the detector means further characterized as measuring light absorption at two closely-spaced wavelengths said first and second wavelengths separated by less than about 60 nanometers in order to minimize inference from extraneous factors.
2 Assignments
0 Petitions
Accused Products
Abstract
Systems and methods for non-invasive blood analysis for the presence of glucose are disclosed in which blood is illuminated at a plurality of discrete wavelengths selected from the near infrared spectrum. Measurements of the intensity of transmitted or reflected light at such wavelengths are taken, and an analysis of transmittance or reflectance ratios for various wavelengths is performed. Changes in the ratios can be correlated with specific near infrared (IR) absorption peak for glucose at about 1600 nm +/-15 nm which varies with concentration of the analyte (the data wavelength) and the a second (reference) wavelength being sufficiently removed from the first so that measurements of light absorption at this second wavelength are relatively insensitive to the concentration of the analyte and yet the second wavelength is sufficiently close to the first wavelength to minimize interference from scattering effects and the like. Typically, the window bracketing these closely spaced wavelengths will be less than about 300 nm and preferably less than about 60 nm wide and, in some instances, more preferably less than about 30 nm wide.
-
Citations
21 Claims
-
1. A blood-glucose detection apparatus comprising:
-
infrared illumination means for non-invasively illuminating an in vivo blood sample in a patient at least two wavelengths in the near infrared spectrum; detector means for non-invasively measuring light absorbed by said sample at least a first glucose data wavelength about 1600 nm and a second reference wavelength, and for converting said detected light into electrical signals, said signals being indicative of the intensity of said detected light at each wavelength; the detector means further characterized as measuring light absorption at two closely-spaced wavelengths said first and second wavelengths separated by less than about 60 nanometers in order to minimize inference from extraneous factors. - View Dependent Claims (2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13)
-
-
14. A method for detecting glucose in a blood sample, comprising the steps of:
-
illuminating a source of blood non-invasively through the tissue of a subject at a plurality of wavelengths within a narrow window selected in the near infrared spectrum; detecting light effected by said blood and converting said detected light into electrical signals indicative of the intensity of said effected light at a plurality of wavelengths selected from the near infrared spectrum, including a first data wavelength and a second reference wavelength separated by less than about 60 nanometers; analyzing said electrical signals to derive a ratio for at least two of said wavelengths; and comparing said ratio to a predetermined value to detect the presence of an analyte in said blood. - View Dependent Claims (15, 16, 17, 18, 19, 20, 21)
-
Specification